Larson Financial Group’s Voyager Therapeutics VYGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$40 Buy
+15
New +$48 ﹤0.01% 3790

Other funds holding VYGR

Larson Financial Group's VYGR Position: Q3 2026 in Review

Larson Financial Group opened a new position in Voyager Therapeutics (VYGR) in Q3 2026: 15 shares worth $40. The stake represents ﹤0.01% of the portfolio and ranks #3790 among its holdings.

121 funds tracked by Wall St. Rank hold VYGR as of Q3 2026.

  • Larson Financial Group held 15 shares of Voyager Therapeutics worth $40 as of Q3 2026.
  • Voyager Therapeutics was a new Larson Financial Group position in Q3 2026.
  • Voyager Therapeutics made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #3790 holding.
  • 121 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.